Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences

Rhea-AI Summary

Ironwood Pharmaceuticals (NASDAQ: IRWD) will participate in two upcoming virtual investor conferences in September 2021. The Wells Fargo Healthcare Conference is scheduled for September 10 at 2:00 p.m. ET, and the Morgan Stanley 19th Annual Global Healthcare Conference will take place on September 13 at 2:45 p.m. ET. Investors can access live webcasts on Ironwood's website, with replays available for 14 days post-conference. Ironwood focuses on developing medicines for gastrointestinal diseases, notably linaclotide for IBS-C and CIC.

BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences in September:

• 2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021 at 2:00 p.m. ET
• Morgan Stanley 19^th Annual Global Healthcare Conference on Monday, September 13, 2021 at 2:45 p.m. ET

A live webcast of Ironwood’s fireside chats will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Ironwood’s website for 14 days following the conference.

About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

Ironwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005017/en/

Investors:

Matt Roache, 617-621-8395

Director, Investor Relations

mroache@ironwoodpharma.com

Source: Ironwood Pharmaceuticals, Inc.

FAQ

When will Ironwood Pharmaceuticals participate in the Wells Fargo Healthcare Conference?

Ironwood Pharmaceuticals will participate in the Wells Fargo Healthcare Conference on September 10, 2021, at 2:00 p.m. ET.

What is the date and time of the Morgan Stanley Healthcare Conference for Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals will be at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13, 2021, at 2:45 p.m. ET.

How can investors access the webcasts for Ironwood Pharmaceuticals' conferences?

Investors can access live webcasts of Ironwood Pharmaceuticals' conferences through the Investors section of their website, starting 15 minutes before the events.

What does Ironwood Pharmaceuticals focus on regarding their healthcare products?

Ironwood Pharmaceuticals is dedicated to creating medicines for gastrointestinal diseases, with linaclotide being their leading product for IBS-C and CIC.

How long will the webcasts from Ironwood Pharmaceuticals' conferences be available for replay?

The webcasts will be available for replay on Ironwood Pharmaceuticals' website for 14 days following the conferences.